| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $35.6M | +136.0% |
| Cost of Revenue | $9.9M | +119.1% |
| Gross Profit | $25.7M | +143.2% |
| R&D Expense | $259.9M | +25.6% |
| SG&A Expense | $138.5M | +82.5% |
| Operating Income | -$372.7M | -36.9% |
| Pre-tax Income | -$745.1M | -170.8% |
| Income Tax | $756K | +47.1% |
| Net Income | -$745.9M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.71B | +467.4% |
| Accounts Receivable | $5.7M | +167.1% |
| Current Assets | $1.74B | +431.4% |
| Total Assets | $2.11B | +216.1% |
| Current Liabilities | $76.4M | +35.1% |
| Long-term Debt | $185.5M | +24.3% |
| Total Liabilities | $288.4M | +25.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$267.8M | -20.3% |
| Capital Expenditures | $45.4M | -38.2% |
| Investing Cash Flow | -$44.1M | +35.9% |
| Financing Cash Flow | $1.73B | +408.4% |
| Free Cash Flow | -$313.2M | -5.8% |
| -170.6% |
| EPS (Basic) | -$12.85 | -89.8% |
| EPS (Diluted) | -$12.85 | -89.8% |
| Stockholders' Equity |
| $1.82B |
| +317.0% |